| Literature DB >> 32370175 |
Sofia Chalvatzi1, Georgios A Papadopoulos1, Vasilios Tsiouris2, Ilias Giannenas3, Ioannis T Karapanagiotidis4, Alexandros Theodoridis5, Ioanna Georgopoulou2, Paschalis D Fortomaris1.
Abstract
Reducing the energy content of broiler diets could lead to the formulation of diets with reduced production cost. Dimethylgycine (DMG) has been used as a dietary supplement to enhance dietary fat utilization in poultry. The objective of the present study was to investigate the effects of DMG supplementation in reduced energy diets on performance and nutrient digestibility in broiler chickens. Four hundred and eighty day-old broilers were randomly allocated to three dietary treatments: a standard energy diet (PC treatment), a reduced energy diet by 66 kcal/kg (NC treatment) and the reduced energy diet supplemented with 500 mg/kg of DMG (DMG treatment). Fat digestibility was significantly higher in DMG group, compared to PC and NC groups. Intestines and gizzard lesion scores were found to be lower in the DMG group compared to PC. DMG supplementation resulted in lower jejunum pH and ileum viscosity in broilers. Overall, the present study showed that DMG supplementation in reduced energy broiler diets restored growth performance to the levels obtained with a standard diet. This result was probably mediated by the positive effects on the gastrointestinal function of the broilers after DMG supplementation, as evidenced by the improved nutrient digestibility, the reduced gross lesion scores and the lower values in intestinal pH and viscosity.Entities:
Keywords: broilers; dimethylgycine; fat digestibility
Year: 2020 PMID: 32370175 PMCID: PMC7277919 DOI: 10.3390/ani10050789
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Ingredient and nutrient composition of the experimental diets according to the stage of growth (on dry matter basis).
| Items | Starter (1–14 d) | Grower (15–28 d) | Finisher (29–42 d) | |||
|---|---|---|---|---|---|---|
| PC a | NC b | PC | NC | PC | NC | |
| Ingredients (g/kg) | ||||||
| Wheat soft | 414.7 | 429.9 | 356.7 | 371.5 | 410.9 | 425.9 |
| Soybean meal 47% | 296.2 | 292.4 | 303.4 | 299.7 | 247.8 | 244.1 |
| Maize | 200.0 | 200.0 | 250.0 | 250.0 | 250.0 | 250.0 |
| Fish meal | 20.0 | 20.0 | - | - | - | - |
| Limestone | 14.3 | 14.3 | 14.1 | 14.1 | 13.4 | 13.4 |
| Soybean oil | 25.4 | 14.0 | 48.4 | 37.1 | 51.1 | 39.7 |
| Monocalcium phoshate | 13.8 | 13.8 | 13.5 | 13.5 | 12.9 | 12.9 |
| Premix c | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 |
| DL—methionine | 3.2 | 3.2 | 2.5 | 2.5 | 2.1 | 2.1 |
| L—Lysine | 2.9 | 3.0 | 2.0 | 2.1 | 2.2 | 2.3 |
| Sodium chloride | 2.1 | 2.0 | 2.3 | 2.3 | 2.2 | 2.2 |
| L—threonine | 1.3 | 1.3 | 0.7 | 0.7 | 0.8 | 0.8 |
| Sodium bicarbonate | 1.1 | 1.1 | 1.4 | 1.5 | 1.6 | 1.6 |
| Nutrient composition d | ||||||
| Crude protein (g/kg) | 220.0 | 220.0 | 205.0 | 205.0 | 185.0 | 185.0 |
| Ether extract (g/kg) | 45.0 | 33.8 | 67.4 | 56.2 | 69.6 | 58.4 |
| AMEn (kcal/kg) | 2970 | 2904 | 3109 | 3043 | 3169 | 3103 |
| Crude fibre (g/kg) | 25.9 | 26.1 | 26 | 26.2 | 25.1 | 25.3 |
| Dig. Lysine (g/kg) | 12.1 | 12.1 | 10.6 | 10.6 | 9.4 | 9.4 |
a PC: positive control diet providing energy based on recommendations. b NC: negative control diet with a nitrogen-corrected apparent metabolizable energy (AMEn) reduced by 66 kcal/kg compared to the positive control diet. c Provided per kg diet: retinyl acetate, 4.2 mg; cholecalciferol, 0.125 mg; αtocopherol acetate, 50 mg; menadione, 7.0 mg; cobalamin, 0.025 mg; folic acid, 2.0 mg; choline, 750 mg; calcium pantothenate, 20.0 mg; riboflavin, 8.0 mg; niacin, 60.0 mg; thiamin, 6.0 mg; D-biotin, 0.2 mg; pyridoxine, 5.0 mg; Mn (from manganese sulphate), 120 mg; Zn (from zinc sulphate), 100 mg; Fe (from ferrous sulphate), 40 mg; Cu (from copper sulphate), 20 mg; I (from calcium iodate), 1.0 mg; Se (from sodium selenite), 0.3 mg. d Calculated value. The DMG diets consisted of the NC diet supplemented with 500 mg DMG/kg of diet.
Performance of broilers in each experimental group, measured at different growth stages.
| Parameter | Period | Treatments | |||
|---|---|---|---|---|---|
| PC | NC | DMG | |||
| Body weight (g) | 1 d | 47.9 ± 0.83 | 47.8 ± 0.72 | 48.4 ± 0.44 | 0.211 |
| 14 d | 351.6 ± 27.63 | 334. 1 ± 20.98 | 361.4 ± 17.88 | 0.118 | |
| 28 d | 1365.7 ± 59.75 | 1290.2 ± 87.45 | 1345.4 ± 58.87 | 0.106 | |
| 42 d | 2544.5 ± 104.79 a | 2392. 3 ± 87.60 b | 2533.0 ± 74.76 a | 0.004 | |
| Body weight gain (g) | 1–14 d | 303.6 ± 27.27 | 286.2 ± 21.06 | 313.0 ± 17.91 | 0.075 |
| 15–28 d | 1014.1 ± 34.51 | 956.1 ± 68.54 | 984.0 ± 50.18 | 0.115 | |
| 29–42 d | 1178.8 ± 67.84 a | 1102.1 ± 64.63 b | 1187.6 ± 57.59 a | 0.026 | |
| 1–42 d | 2496.6 ± 104.81 a | 2344.4 ± 87.44 b | 2484.6 ± 74.76 a | 0.004 | |
| Feed intake (g) | 1–14 d | 454.4 ± 25.44 | 447.2 ± 23.69 | 470.1 ± 31.72 | 0.251 |
| 15–28 d | 1558.9 ± 96.20 | 1548.7 ± 111.71 | 1577.0 ± 69.78 | 0.832 | |
| 29–42 d | 2171.8 ± 86.10 a,b | 2106.1 ± 112.06 b | 2231.3 ± 61.51 a | 0.035 | |
| 1–42 d | 4185.2 ± 151.42 | 4102.0 ± 227.76 | 4278.4 ± 109.16 | 0.141 | |
| Feed conversion ratio (g:g) | 1–14 d | 1.50 ± 0.08 | 1.57 ± 0.09 | 1.50 ± 0.03 | 0.126 |
| 15–28 d | 1.54 ± 0.10 | 1.63 ± 0.14 | 1.61 ± 0.11 | 0.328 | |
| 29–42 d | 1.84 ± 0.06 | 1.92 ± 0.15 | 1.88 ± 0.07 | 0.383 | |
| 1–42 d | 1.68 ± 0.06 | 1.75 ± 0.09 | 1.72 ± 0.05 | 0.136 | |
Mean ± standard deviation; a,b mean values in the same row with a different superscript differ significantly (p ≤ 0.05).
Mean values of nutrient digestibility in each experimental group.
| Parameter | Treatments | |||
|---|---|---|---|---|
| PC | NC | DMG | ||
| Dry matter digestibility (%) | 80.8 ± 3.38 | 77.9 ± 2.26 | 80.9 ± 3.78 | 0.400 |
| Crude protein digestibility (%) | 72.6 ± 4.77 a,b | 69.3 ± 3.68 b | 74.4 ± 2.67 a | 0.046 |
| Crude fat digestibility (%) | 77.6 ± 4.15 b | 80.1 ± 5.82 b | 85.5 ± 4.57 a | 0.014 |
| AMEn (kcal/kg) | 3079 ± 65.88 a | 2970 ± 65.25 b | 3049 ± 90.16 a | 0.023 |
Mean ± standard deviation; a,b Mean values in the same row with a different superscript differ significantly (p ≤ 0.05).
Mean grade of lesion scores in the intestine, liver and gizzard in each experimental group.
| Organ | Age | Treatments | |||
|---|---|---|---|---|---|
| PC | NC | DMG | |||
| Intestine | 14 | 1.70 ± 0.68 | 1.50 ± 0.53 | 1.40 ± 0.52 | 0.505 |
| 28 | 2.80 ± 0.42 a | 2.30 ± 0.68 b | 1.90 ± 0.32 b | 0.002 | |
| 42 | 1.70 ± 0.68 a | 1.40 ± 0.52 a,b | 1.00 ± 0.00 b | 0.013 | |
| Liver | 14 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | - |
| 28 | 0.00 ± 0.00 b | 0.70 ± 0.95 a | 0.00 ± 0.00 b | 0.010 | |
| 42 | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | - | |
| Gizzard | 14 | 1.00 ± 0.82 | 1.20 ± 0.63 | 1.00 ± 0.67 | 0.769 |
| 28 | 0.30 ± 0.48 b | 1.00 ± 0.82 a | 0.10 ± 0.32 b | 0.004 | |
| 42 | 0.60 ± 0.52 a | 0.20 ± 0.42 b | 0.10 ±0.32 b | 0.034 | |
Mean ± standard deviation; a, b mean values in the same row with a different superscript differ significantly (p ≤ 0.05). For mean value estimation, eight samples per treatment were considered. Intestinal gross lesions scoring system: 1 = normal intestinal mucosa; 2 = hyperaemia of intestinal mucosa and/or undigested intestinal content in the last third of the intestine; 3 = congestion and thickness of intestinal mucosa and/or watery intestinal content; 4 = haemorrhages of intestinal mucosa. Gizzard gross lesions scoring system: 0 = normal gizzard; 1 = erosion of cuticula of gizzard; 2 = ulcers of cuticula of gizzard. Liver gross lesions scoring system: 0 = normal liver, gall bladder and bile; 1 = congestion of liver and/or thickness and distention of gall bladder and/or discoloration of bile; 2 = necrotic lesions of liver.
Average values of pH and viscosity at different parts of the intestine, measured at 28 and 42 days of age.
| Parameter | Age | Treatments | |||
|---|---|---|---|---|---|
| PC | NC | DMG | |||
| pH duodenum | 28 | 6.82 ± 0.09 | 6.68 ± 0.21 | 6.72 ± 0.12 | 0.125 |
| pH duodenum | 42 | 6.26 ± 0.25 | 6.34 ± 0.17 | 6.34 ± 0.13 | 0.595 |
| pH jejunum | 28 | 6.65 ± 0.11 a | 6.37 ± 0.09 b | 6.38 ± 0.09 b | <0.001 |
| pH jejunum | 42 | 6.24 ± 0.11 ab | 6.34 ± 0.18 a | 6.16 ± 0.15 b | 0.043 |
| pH ileum | 28 | 6.73 ± 0.16 b | 6.89 ± 0.59 b | 7.53 ± 0.44 a | 0.001 |
| pH ileum | 42 | 7.06 ± 1.17 | 7.34 ± 0.62 | 6.66 ± 0,66 | 0.228 |
| pH caecum | 28 | 7.03 ± 0.85 ab | 7.26 ± 0.52 a | 6.48 ± 0.34 b | 0.025 |
| pH caecum | 42 | 7.03 ± 0.46 | 7.24 ± 0.47 | 7.15 ± 0.46 | 0.584 |
| Viscosity jejunum | 28 | 2.41 ± 0.40 | 2.07 ± 0.37 | 2.28 ± 0.28 | 0.172 |
| Viscosity jejunum | 42 | 1.80 ± 0.54 | 1.74 ± 0.45 | 1.46 ± 0.25 | 0.200 |
| Viscosity ileum | 28 | 2.57 ± 0.92 | 3.82 ± 1.05 | 3.45 ± 0.96 | 0.487 |
| Viscosity ileum | 42 | 2.64 ± 0.47 b | 3.80 ± 1.08 a | 2.81 ± 0.60 b | 0.011 |
Mean ± standard deviation; a, b mean values in the same row with a different superscript differ significantly (p ≤ 0.05). For mean value estimation, eight samples per treatment were considered.